ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00099437
Brief Title: Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. (CONFIRM)

First Submitted : December 13, 2004
First Submitted that Met QC Criteria : December 13, 2004
First Posted : December 14, 2004 (Estimate)

Results First Submitted : February 23, 2010
Results First Submitted that Met QC Criteria : May 12, 2010
Results First Posted : June 15, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : June 5, 2018
Last Update Posted : June 7, 2018